newsfilter
← Latest News
Business Wire·

Sierra Oncology Reports Third Quarter 2021 Results

– MOMENTUM study on track for topline data read-out by February 2022 – – Global in-licensing deal expands myelofibrosis pipeline and provides options for combination studies in other hematologic malignancies and solid tumors – Sierra Oncol